CVS Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Narratives
BetaNarratives bring a range of perspectives from our community.
Warren
Based on Analyst Price Targets
Price at publication US$76.42
Updated
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$67.33 |
| 52 Week High | US$83.25 |
| 52 Week Low | US$64.41 |
| Beta | 0.51 |
| 1 Month Change | -15.12% |
| 3 Month Change | -7.77% |
| 1 Year Change | -7.84% |
| 3 Year Change | -11.84% |
| 5 Year Change | 18.69% |
| Change since IPO | 10,155.56% |
Recent News & Updates
CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14
CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Recent updates
CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20CVS Health Offers Recession-Resistant Growth With Transformation
Oct 05CVS Stock: The Risk-Reward Is In A Better Place
Sep 18CVS Health: Share Price Suffers As Business Transformation Flounders
Aug 25Is CVS Health (NYSE:CVS) A Risky Investment?
Aug 25Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation
Aug 16CVS Health: Second Quarter Was Only Decent, But Integration Is On Track
Aug 03Shareholder Returns
| CVS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -3.0% | 0.6% | 1.0% |
| 1Y | -7.8% | 2.2% | 21.9% |
Return vs Industry: CVS underperformed the US Healthcare industry which returned 2.2% over the past year.
Return vs Market: CVS underperformed the US Market which returned 21.9% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | US$84.87b |
| Earnings (TTM) | US$8.34b |
| Revenue (TTM) | US$356.62b |
10.2x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$356.62b |
| Cost of Revenue | US$303.35b |
| Gross Profit | US$53.28b |
| Other Expenses | US$44.93b |
| Earnings | US$8.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 6.62 |
| Gross Margin | 14.94% |
| Net Profit Margin | 2.34% |
| Debt/Equity Ratio | 78.6% |
How did CVS perform over the long term?
See historical performance and comparison